Patrycja Brzozowska
Patrycja Brzozowska has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Bianka Nowińska
Military Clinical Hospital SP ZOZ, Weigla 5, 53-114 Wrocław, Poland
9 shared publications - Bartosz Siudek
A. Falkiewicz Specialist Hospital, 52-114 Wrocław, Poland
4 shared publications - Karina Lissak
Lower Silesian Oncology Center
4 shared publications - Olgierd Dróżdż
Clinical Department of Diabetology, Hypertension and Internal Diseases, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland
4 shared publications - Wiktoria Bińczyk
Wroclaw Medical University, Faculty of Medicine, Borowska str. 213, 50-556 Wroclaw, Poland
4 shared publications - Andrzej Piela
University Clinical Hospital named after Fryderyk Chopin in Rzeszów, st. Fryderyk Szopen 2, 35-055 Rzeszów, Poland
3 shared publications
Latest Publications
- Open Access
- 7 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 18, 53394
Re-diagnosis of diabetes mellitus type 1 to maturity-onset diabetes of the young type 2 (MODY 2) in a 26-year-old male: a case report
Diabetes mellitus (DM) encompasses a spectrum of metabolic disorders characterized by hyperglycemia due to defects in insulin secretion, action, or both. Type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) are the most prevalent forms, whereas Maturity-Onset Diabetes of the Young (MODY) represents a monogenic subtype, often misdiagnosed due to its phenotypic overlap. This case study highlights a 26-year-old male initially diagnosed with T1DM at age 12, managed with insulin therapy. Upon admission, despite stable glycemic control and preserved C-peptide secretion, genetic testing revealed MODY 2 due to a variant in the GCK gene. Unlike T1DM and T2DM, MODY 2 is characterized by mild, persistent hyperglycemia with a low risk of complications, emphasizing the importance of genetic diagnosis for tailored management and family counseling. This case underscores the critical role of genetic evaluation in accurately diagnosing and managing atypical diabetes presentations.
- 7 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 18, 53394
Open AccessRe-diagnosis of diabetes mellitus type 1 to maturity-onset diabetes of the young type 2 (MODY 2) in a 26-year-old male: a case report
Diabetes mellitus (DM) encompasses a spectrum of metabolic disorders characterized by hyperglycemia due to defects in insulin secretion, action, or both. Type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) are the most prevalent forms, whereas Maturity-Onset Diabetes of the Young (MODY) represents a monogenic subtype, often misdiagnosed due to its phenotypic overlap. This case study highlights a 26-year-old male initially diagnosed with T1DM at age 12, managed with insulin therapy. Upon admission, despite stable glycemic control and preserved C-peptide secretion, genetic testing revealed MODY 2 due to a variant in the GCK gene. Unlike T1DM and T2DM, MODY 2 is characterized by mild, persistent hyperglycemia with a low risk of complications, emphasizing the importance of genetic diagnosis for tailored management and family counseling. This case underscores the critical role of genetic evaluation in accurately diagnosing and managing atypical diabetes presentations.
- Open Access
- 25 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 18, 52945
Severe case of antiphospholipid syndrome coexisting with systemic lupus erythematosus with major cardiovascular complications: a case report
Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are autoimmune diseases that frequently coexist, complicating clinical management due to the compounded risks of systemic inflammation and thromboembolism. We present a case of a 52-year-old female with SLE and APS, initially diagnosed after a pulmonary embolism in 2015. Her medical history includes recurrent anemia, hyperlipidemia, hypertension, and two myocardial infarctions treated with angioplasty and stenting. Despite treatment with hydroxychloroquine, methylprednisolone, methotrexate and apixaban (later switched to warfarin), the patient experienced severe disease flare-ups and cardiovascular complications, prompting consideration for biologic therapy with anifrolumab. This case study illustrates the difficulties associated with the management of concurrent SLE and APS. It is clear that early diagnosis, vigilant monitoring, and aggressive management of both autoimmune and cardiovascular risks are essential to improve patient outcomes.
- 25 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 18, 52945
Open AccessSevere case of antiphospholipid syndrome coexisting with systemic lupus erythematosus with major cardiovascular complications: a case report
Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are autoimmune diseases that frequently coexist, complicating clinical management due to the compounded risks of systemic inflammation and thromboembolism. We present a case of a 52-year-old female with SLE and APS, initially diagnosed after a pulmonary embolism in 2015. Her medical history includes recurrent anemia, hyperlipidemia, hypertension, and two myocardial infarctions treated with angioplasty and stenting. Despite treatment with hydroxychloroquine, methylprednisolone, methotrexate and apixaban (later switched to warfarin), the patient experienced severe disease flare-ups and cardiovascular complications, prompting consideration for biologic therapy with anifrolumab. This case study illustrates the difficulties associated with the management of concurrent SLE and APS. It is clear that early diagnosis, vigilant monitoring, and aggressive management of both autoimmune and cardiovascular risks are essential to improve patient outcomes.
- Open Access
- 12 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52375
Topical Treatment and Aesthetic Procedures in Management of Acne Vulgaris
Acne vulgaris is a common, chronic inflammatory skin disease affecting up to 80% of young adults and adolescents. The pathogenesis of acne is multifactorial and involves the pilosebaceous units of the skin. As a result of the disease process, skin lesions such as open and closed comedones, nodules, pustules, and papules appear on the skin. In recent years, acne has been increasingly observed in younger patients, which is associated with the earlier onset of puberty. Moreover, acne is increasingly diagnosed in individuals over 20 years of age, particularly in women, which is referred to as adult female acne (AFA). Effective and rapid implementation of treatment is crucial to prevent complications such as post-inflammatory hyperpigmentation and acne scars, as well as to mitigate the negative psychological impact of the disease on patients. The article discusses both topical treatment and aesthetic medicine procedures in the management of acne vulgaris. Topical treatments include the use of retinoids, antibiotics, benzoyl peroxide, clascoterone, dapsone, azelaic acid, and combination therapies. Aesthetic procedures such as chemical peels, microdermabrasion, photodynamic therapy, blue light therapy, and laser therapies can be beneficial as adjunctive treatments. The article also addresses the issue of acne as a comorbid condition in patients seeking aesthetic medicine treatments, even if it is not the primary reason for their visit.
- 12 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52375
Open AccessTopical Treatment and Aesthetic Procedures in Management of Acne Vulgaris
Acne vulgaris is a common, chronic inflammatory skin disease affecting up to 80% of young adults and adolescents. The pathogenesis of acne is multifactorial and involves the pilosebaceous units of the skin. As a result of the disease process, skin lesions such as open and closed comedones, nodules, pustules, and papules appear on the skin. In recent years, acne has been increasingly observed in younger patients, which is associated with the earlier onset of puberty. Moreover, acne is increasingly diagnosed in individuals over 20 years of age, particularly in women, which is referred to as adult female acne (AFA). Effective and rapid implementation of treatment is crucial to prevent complications such as post-inflammatory hyperpigmentation and acne scars, as well as to mitigate the negative psychological impact of the disease on patients. The article discusses both topical treatment and aesthetic medicine procedures in the management of acne vulgaris. Topical treatments include the use of retinoids, antibiotics, benzoyl peroxide, clascoterone, dapsone, azelaic acid, and combination therapies. Aesthetic procedures such as chemical peels, microdermabrasion, photodynamic therapy, blue light therapy, and laser therapies can be beneficial as adjunctive treatments. The article also addresses the issue of acne as a comorbid condition in patients seeking aesthetic medicine treatments, even if it is not the primary reason for their visit.
- Open Access
- 10 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52628
The effectiveness of ketamine in medication of treatment-resistant depression - review
In spite of the variety of antidepressant drugs available for treating depressive disorder, treatment resistant depression (TRD) is still prevalent among the population. Despite being used mainly in anesthesia, and mostly phased out by more modern anesthetics, ketamine shows potential when it comes to depressive disorder treatment. We've set out to investigate the the relevant body of work to determine the efficacy of ketamine usage in patients with TRD. Research shows that usage of ketamine used in patients with TRD leads to mood elevation, better cognitive functions, sleep and appetite. Moreover, ketamine is shown to decrease suicidal thoughts and shows potential in acute actions in emergency situations, especially with its faster effects when compared to traditional antidepressants. Some research show significant reduction in suicidal thoughts after just one infusion of ketamine. Clinicians have developed intranasal, subcutaneous, intramuscular and oral ways of administering ketamine, which, though less bioavailable, when compered to intravenous use, are much more convenient and less expensive for the patients. All those ways of administering the drug have their upsides and downsides, and theres still debate on which is best. Ketamine shows promise in patients with TRD. Some studies show that up to 70% of people with TRD response to ketamine, which might show efficacy of ketamine usage in those patients State of knowledge: Despite extensive research in the field of depression treatment, there's considerable lack of comprehensive reviews of efficacy of ketamine usage in cases where traditional ways of treating depression have failed. In the face of increasing number cases of treatment resistant depression worldwide, this paper aims to gather research papers regarding this topic and synthesize it into comprehensive review.
- 10 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52628
Open AccessThe effectiveness of ketamine in medication of treatment-resistant depression - review
In spite of the variety of antidepressant drugs available for treating depressive disorder, treatment resistant depression (TRD) is still prevalent among the population. Despite being used mainly in anesthesia, and mostly phased out by more modern anesthetics, ketamine shows potential when it comes to depressive disorder treatment. We've set out to investigate the the relevant body of work to determine the efficacy of ketamine usage in patients with TRD. Research shows that usage of ketamine used in patients with TRD leads to mood elevation, better cognitive functions, sleep and appetite. Moreover, ketamine is shown to decrease suicidal thoughts and shows potential in acute actions in emergency situations, especially with its faster effects when compared to traditional antidepressants. Some research show significant reduction in suicidal thoughts after just one infusion of ketamine. Clinicians have developed intranasal, subcutaneous, intramuscular and oral ways of administering ketamine, which, though less bioavailable, when compered to intravenous use, are much more convenient and less expensive for the patients. All those ways of administering the drug have their upsides and downsides, and theres still debate on which is best. Ketamine shows promise in patients with TRD. Some studies show that up to 70% of people with TRD response to ketamine, which might show efficacy of ketamine usage in those patients State of knowledge: Despite extensive research in the field of depression treatment, there's considerable lack of comprehensive reviews of efficacy of ketamine usage in cases where traditional ways of treating depression have failed. In the face of increasing number cases of treatment resistant depression worldwide, this paper aims to gather research papers regarding this topic and synthesize it into comprehensive review.
- Open Access
- 10 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52676
A case report: acute sinusitis turned into shockingly rapid sepsis at young male adult
Sinusitis is a disease of usually mild course - however, sometimes secondary diseases might develop such as pneumonia which might have moderate to severe course. Pneumonia is usually treated ambulatory, regardless some patients’ state worsens and they are in need of hospital treatment, sometimes even in Intensive Care Unit. In this article is presented a case of a patient with such history - a young adult with no medical history of chronic diseases, whose state worsened and required ICU treatment.
- 10 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52676
Open AccessA case report: acute sinusitis turned into shockingly rapid sepsis at young male adult
Sinusitis is a disease of usually mild course - however, sometimes secondary diseases might develop such as pneumonia which might have moderate to severe course. Pneumonia is usually treated ambulatory, regardless some patients’ state worsens and they are in need of hospital treatment, sometimes even in Intensive Care Unit. In this article is presented a case of a patient with such history - a young adult with no medical history of chronic diseases, whose state worsened and required ICU treatment.
- Open Access
- 7 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52210
The Impact of Physical Activity on Gut Microbiota: An In-Depth Literature Review
Introduction. The human body is home to a diverse community of microorganisms known as the microbiota. These microorganisms, including bacteria, fungi, and viruses, play crucial roles in maintaining overall health. They colonize the digestive tract shortly after birth, and the composition of the gut microbiota changes throughout an individual's life, largely influenced by diet and physical activity. Breastfeeding has long-term beneficial effects on the gut microbiota and gene expression in intestinal cells. Regular exercise not only improves cardiovascular and respiratory health but also affects metabolic, immunological, neural, and microbial pathways. This review explores how diet and physical activity impact the composition and diversity of gut microbiota, highlighting important findings and their implications for health. Aim of study. This study aims to review how physical activity influences gut microbiota, investigating the effects of different types and intensities of exercise on microbial composition and diversity, and their implications for overall health. Materials and methods. A non-systematic examination of the scientific literature was conducted using specific keywords such as gut microbiota, physical activity, sport, and microbiome. The examination took place on PubMed, with scrutiny of a total of 31 references published up to 2023. Conclusions. This review highlights the crucial role of gut microbiota in maintaining good health and its complex interaction with diet and physical activity. Regular exercise has a positive impact on the diversity of microbiota, especially when started at a young age. Imbalance in gut bacteria is linked to various diseases, underscoring the significance of a healthy microbiome. Encouraging physical activity and a nutritious diet can improve gut health, and more research is needed to understand the mechanisms and potential health indicators involved.
- 7 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52210
Open AccessThe Impact of Physical Activity on Gut Microbiota: An In-Depth Literature Review
Introduction. The human body is home to a diverse community of microorganisms known as the microbiota. These microorganisms, including bacteria, fungi, and viruses, play crucial roles in maintaining overall health. They colonize the digestive tract shortly after birth, and the composition of the gut microbiota changes throughout an individual's life, largely influenced by diet and physical activity. Breastfeeding has long-term beneficial effects on the gut microbiota and gene expression in intestinal cells. Regular exercise not only improves cardiovascular and respiratory health but also affects metabolic, immunological, neural, and microbial pathways. This review explores how diet and physical activity impact the composition and diversity of gut microbiota, highlighting important findings and their implications for health. Aim of study. This study aims to review how physical activity influences gut microbiota, investigating the effects of different types and intensities of exercise on microbial composition and diversity, and their implications for overall health. Materials and methods. A non-systematic examination of the scientific literature was conducted using specific keywords such as gut microbiota, physical activity, sport, and microbiome. The examination took place on PubMed, with scrutiny of a total of 31 references published up to 2023. Conclusions. This review highlights the crucial role of gut microbiota in maintaining good health and its complex interaction with diet and physical activity. Regular exercise has a positive impact on the diversity of microbiota, especially when started at a young age. Imbalance in gut bacteria is linked to various diseases, underscoring the significance of a healthy microbiome. Encouraging physical activity and a nutritious diet can improve gut health, and more research is needed to understand the mechanisms and potential health indicators involved.
- Open Access
- 5 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 15
Retatrutide - revolutionary recently developed GLP agonist - literature review
Obesity - defined by excessive amount of fat tissue - is becoming more and more serious health problem among our population and affecting a growing number of people [1]. It is crucial in treatment to encourage and adjust patients to increased physical activity and decreased food consumption. However, it its much easier said than done, resulting in lowered motivation and many failed attempts at patients which makes it more difficult to engage in weight loss process. Holistic approach from medical team is crucial. More drugs are becoming approved in treatment of obesity - which is a big step for patients having a high body mass index (BMI) for whom diet and exercise might not be enough in order to lose weight. One of these drugs is retatrutide which appears to be a game-changer amongst other medications. It is revolutionary since it is a „triple G” agonist - it affects glucagon-like peptide (GLP) receptors, glucose-dependent insulotropic polypeptide (GIP) receptors and glucagon (GCG) receptors. It is a first substance of already available weight loss drugs that affects all three mentioned receptors - eg. semaglutide is a GLP receptor agonist and recently developed tirzepatide is a GLP and GIP receptors agonist. It could lead to revolutionizing weight loss treatments industry, making it even more successful and efficient. The aim of our study is to describe this new drug, its’ mechanism of action and discuss possible benefits versus adverse effects.
- 5 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 15
Open AccessRetatrutide - revolutionary recently developed GLP agonist - literature review
Obesity - defined by excessive amount of fat tissue - is becoming more and more serious health problem among our population and affecting a growing number of people [1]. It is crucial in treatment to encourage and adjust patients to increased physical activity and decreased food consumption. However, it its much easier said than done, resulting in lowered motivation and many failed attempts at patients which makes it more difficult to engage in weight loss process. Holistic approach from medical team is crucial. More drugs are becoming approved in treatment of obesity - which is a big step for patients having a high body mass index (BMI) for whom diet and exercise might not be enough in order to lose weight. One of these drugs is retatrutide which appears to be a game-changer amongst other medications. It is revolutionary since it is a „triple G” agonist - it affects glucagon-like peptide (GLP) receptors, glucose-dependent insulotropic polypeptide (GIP) receptors and glucagon (GCG) receptors. It is a first substance of already available weight loss drugs that affects all three mentioned receptors - eg. semaglutide is a GLP receptor agonist and recently developed tirzepatide is a GLP and GIP receptors agonist. It could lead to revolutionizing weight loss treatments industry, making it even more successful and efficient. The aim of our study is to describe this new drug, its’ mechanism of action and discuss possible benefits versus adverse effects.
- Open Access
- 3 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 15, 51889
Botulinum toxin in management of back pain
Introduction The botulinum toxin is a widely used therapeutic agent. It is used for aesthetic reasons in treatment of glabellar wrinkles. Therapeutic indications include cervical dystonia, hyperhidrosis or migrenes. Also, it can be used in pain management, especially back pain. Back pain is one of the most common pain syndromes decreasing quality of life. Treatment involves various methods such as conservative and surgical approach. One of the methods is botulinum toxin. Objectives This article aims to evaluate usage, mechanism and treatment effects of back pain using botulinum toxin. Methods A Literature review of articles published in Pubmed between 2000 and 2024 using following words “botulinum toxin”, “botulinum”, “back pain” and “treatment”. Results Botulinum toxin injections are one of the pain management methods used especially in low back pain and myofascial pain syndrome. Treatment relies on its myorelaxant properties and inhibition of neuromodulator secretion such as substance P or acetylocholine. Pain relief effects are noted after three weeks and can last up to six months. In the initial stages a significant amount of patients report relief of pain. Conclusion Botulinum toxin is one of the treatment methods for lower back pain. It is a safe, minimally invasive and effective treatment. Patients can feel the relief even in three weeks and the effects might persist even up to six months.
- 3 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 15, 51889
Open AccessBotulinum toxin in management of back pain
Introduction The botulinum toxin is a widely used therapeutic agent. It is used for aesthetic reasons in treatment of glabellar wrinkles. Therapeutic indications include cervical dystonia, hyperhidrosis or migrenes. Also, it can be used in pain management, especially back pain. Back pain is one of the most common pain syndromes decreasing quality of life. Treatment involves various methods such as conservative and surgical approach. One of the methods is botulinum toxin. Objectives This article aims to evaluate usage, mechanism and treatment effects of back pain using botulinum toxin. Methods A Literature review of articles published in Pubmed between 2000 and 2024 using following words “botulinum toxin”, “botulinum”, “back pain” and “treatment”. Results Botulinum toxin injections are one of the pain management methods used especially in low back pain and myofascial pain syndrome. Treatment relies on its myorelaxant properties and inhibition of neuromodulator secretion such as substance P or acetylocholine. Pain relief effects are noted after three weeks and can last up to six months. In the initial stages a significant amount of patients report relief of pain. Conclusion Botulinum toxin is one of the treatment methods for lower back pain. It is a safe, minimally invasive and effective treatment. Patients can feel the relief even in three weeks and the effects might persist even up to six months.
- Open Access
- 12 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 73, 51728
How to find and overcome reason of the pain - an overview of the possible approaches in intracranial hypotension treatment
Intracranial hypotension syndrome develops following cerebrospinal fluid (CSF, cerebrospinal fluid) leakage as a result of iatrogenic or spontaneous interruption of the meninges. The main clinical manifestation of intracranial hypotension, whether spontaneous (SIH, spontaneous intracranial hypotension) or iatrogenic, is a chronic headache of the orthostatic type, which may be accompanied by symptoms of neurological deficits. Despite the usually benign course, subdural haematomas developing following SIH or cerebral venous sinus thrombosis can cause deterioration of the patient's condition and may even be life-threatening. An important role in the diagnosis of SIH is played by imaging studies (mainly magnetic resonance imaging) of the brain and spinal canal, sometimes supplemented by CSF pressure testing. If conservative treatment fails, consideration should be given to surgical management and epidural blood patch. SIH is dangerous, so it is important to know how to diagnose and treat it.
- 12 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 73, 51728
Open AccessHow to find and overcome reason of the pain - an overview of the possible approaches in intracranial hypotension treatment
Intracranial hypotension syndrome develops following cerebrospinal fluid (CSF, cerebrospinal fluid) leakage as a result of iatrogenic or spontaneous interruption of the meninges. The main clinical manifestation of intracranial hypotension, whether spontaneous (SIH, spontaneous intracranial hypotension) or iatrogenic, is a chronic headache of the orthostatic type, which may be accompanied by symptoms of neurological deficits. Despite the usually benign course, subdural haematomas developing following SIH or cerebral venous sinus thrombosis can cause deterioration of the patient's condition and may even be life-threatening. An important role in the diagnosis of SIH is played by imaging studies (mainly magnetic resonance imaging) of the brain and spinal canal, sometimes supplemented by CSF pressure testing. If conservative treatment fails, consideration should be given to surgical management and epidural blood patch. SIH is dangerous, so it is important to know how to diagnose and treat it.
- 1 June 2021
- Published by Evereth Publishing in Forum Zakażeń
- Vol. 12 (3) , 115-122
Porównanie metod oznaczania wrażliwości na flukonazol klinicznych szczepów Candida
Grzyby z rodzaju Candida odpowiedzialne są m.in. za zapalenie pochwy i sromu oraz kandydemię. Jednym z kluczowych elementów diagnostyki mikologicznej wymienionych zakażeń jest oznaczanie lekowrażliwości grzybów na różne leki przeciwdrobnoustrojowe, w tym flukonazol. W rutynowej diagnostyce wrażliwość na flukonazol jest wyznaczana najczęściej za pomocą pasków z gradientem stężeń (tzw. E-testów). Za metody referencyjne uznawane są dwa nieznacznie różniące się od siebie schematy wyznaczania MIC flukonazolu – opracowane przez EUCAST oraz CLSI. Celem pracy było porównanie wartości MIC otrzymanych z zastosowaniem obu metod referencyjnych oraz otrzymanych przy użyciu E-testów. Zbadano 32 szczepy kliniczne i 4 szczepy referencyjne. Na podstawie otrzymanych wyników szczepy zostały zaklasyfikowane jako wrażliwe na flukonazol, oporne lub wrażliwe w zależności od dawki. Uzyskane wartości MIC różniły się zależnie od zastosowanej metody. Zdecydowana większość szczepów została zaklasyfikowana do tych samych kategorii lekowrażliwości, niezależnie od wybranego schematu postępowania. Pojedyncze niezgodności dotyczyły głównie szczepów NCAC. Różnice w zakresie otrzymanych wyników – zarówno wartości MIC, jak i klasyfikacji klinicznej szczepów do odpowiednich kategorii – wymagają dalszej weryfikacji i ustalenia przyczyn ich występowania.
- 1 June 2021
- Published by Evereth Publishing in Forum Zakażeń
- Vol. 12 (3) , 115-122
Porównanie metod oznaczania wrażliwości na flukonazol klinicznych szczepów Candida
Grzyby z rodzaju Candida odpowiedzialne są m.in. za zapalenie pochwy i sromu oraz kandydemię. Jednym z kluczowych elementów diagnostyki mikologicznej wymienionych zakażeń jest oznaczanie lekowrażliwości grzybów na różne leki przeciwdrobnoustrojowe, w tym flukonazol. W rutynowej diagnostyce wrażliwość na flukonazol jest wyznaczana najczęściej za pomocą pasków z gradientem stężeń (tzw. E-testów). Za metody referencyjne uznawane są dwa nieznacznie różniące się od siebie schematy wyznaczania MIC flukonazolu – opracowane przez EUCAST oraz CLSI. Celem pracy było porównanie wartości MIC otrzymanych z zastosowaniem obu metod referencyjnych oraz otrzymanych przy użyciu E-testów. Zbadano 32 szczepy kliniczne i 4 szczepy referencyjne. Na podstawie otrzymanych wyników szczepy zostały zaklasyfikowane jako wrażliwe na flukonazol, oporne lub wrażliwe w zależności od dawki. Uzyskane wartości MIC różniły się zależnie od zastosowanej metody. Zdecydowana większość szczepów została zaklasyfikowana do tych samych kategorii lekowrażliwości, niezależnie od wybranego schematu postępowania. Pojedyncze niezgodności dotyczyły głównie szczepów NCAC. Różnice w zakresie otrzymanych wyników – zarówno wartości MIC, jak i klasyfikacji klinicznej szczepów do odpowiednich kategorii – wymagają dalszej weryfikacji i ustalenia przyczyn ich występowania.